#R-273063
pecial projects.
Responsibilities:
Acquire and maintain a level of medical-scientific knowledge in the assigned therapeutic area(s) and/or disease state(s) related to CSL Canada's products. Accurately and compliantly interpret and disseminate balanced and factual scientific, clinical, and health economic data. Gather and evaluate new information as it applies to CSL products and areas of therapeutic interest (iron deficiency and cardio-renal therapies).
Identify appropriate regional Key Opinion Leaders (KOLs) and Healthcare Professionals (HCPs) with which to develop professional relationships to ensure exchange of medical-scientific information relevant to CSL Canada products and areas of therapeutic interest.
Deliver approved educational programs to relevant healthcare audiences (e.g. HCPs, Managed Care Organizations, Specialty Pharmacies).
Provide areas of interest and general high-level information regarding CSL Independent Investigator Study (IIS) Program process in response to unsolicited requests. Communicate progress for those IISs approved and supported.
Gather, translate, and communicate actionable, strategy-aligned insights from scientific, educational, and conference setting interactions.
Attend scientific and medical meetings.
Qualifications:
Doctoral level degree in a Medical and/or scientific field is preferred.
Degree in a Medical and/or scientific field with strong relevant experience will be considered.
Minimum of 3 years in the pharmaceutical industry or healthcare experience is required.
Prior MSL experience is required.
Must be able to organize, prioritize, and work effectively in a dynamic, field-based environment
Language requirement: English
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://https://www.csl.com/accessibility-statement.